SCHEMBL6787339

SCHEMBL6787339

CSc1ccc2[nH]c3cnn(C)c3c(=O)c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.48
ALDH1A1 P00352 4/20 0.48
HPGD P15428 3/20 0.48
GAA P10253 3/20 0.48
HSD17B10 Q99714 2/20 0.48
MAPT P10636 2/20 0.48
TSHR P16473 1/20 0.48
CCNB2 O95067 1/20 0.36
CDK1 P06493 1/20 0.36
CCNB1 P14635 1/20 0.36
GSK3B P49841 1/20 0.36
CCNB3 Q8WWL7 1/20 0.36
TYMS P04818 1/20 0.35
POLB P06746 2/20 0.33
HTR6 P50406 2/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
KMT2A Q03164 1/20 0.33
WEE1 P30291 1/20 0.33
TUBB4A P04350 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6781520 0.82 MEN1 (0.53) KDM4EALDH1A1HPGDGAAHSD17B10
SCHEMBL6786900 0.81 KDM4E (0.51) KDM4EALDH1A1HPGDGAAHSD17B10
SCHEMBL14255815 0.78 ABCG2 (0.56) KDM4EALDH1A1HPGDGAAHSD17B10
SCHEMBL6789023 0.78 SMN1; SMN2 (0.47) KDM4EALDH1A1HSD17B10POLBNPC1
SCHEMBL6785969 0.76 CTSV (0.56) ALDH1A1MAPTPOLBMEN1NPC1
SCHEMBL6792539 0.76 GRIN2D (0.36) KDM4EALDH1A1HPGDGAAHSD17B10
SCHEMBL6784943 0.74 AXL (0.49) KDM4EALDH1A1GAAMAPTPOLB
SCHEMBL6785795 0.74 GABRA1 (0.44) KDM4EALDH1A1HSD17B10POLBGABRA1
SCHEMBL6787118 0.74 MPO (0.38) KDM4EALDH1A1HPGDGAAHSD17B10
SCHEMBL6782703 0.74 KIF11 (0.43) GAAPOLBMEN1KMT2AWEE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686373-B2 ANALGESICS; ANTIINFLAMMATORY AGENT WARNER-LAMBERT COMPANY LLC 2004-02-03 US disclosed
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors KAWAMURA KIYOSHI (JP) 2003-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PRKCB, PRKCA, PRKCG KDM4E 1349/4885ALDH1A1 3069/4885HPGD 2987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.